Dyslipidemia: management using optimal lipid-lowering therapy.
about
Mortality is associated with inflammation, anemia, specific diseases and treatments, and molecular markersFactors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International StudyPrevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS)Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment.Stereospecific cross-coupling reactions of aryl-substituted tetrahydrofurans, tetrahydropyrans, and lactones.Standard and intensive lipid-lowering therapy with statins for the primary prevention of vascular diseases: a population-based study.
P2860
Dyslipidemia: management using optimal lipid-lowering therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dyslipidemia: management using optimal lipid-lowering therapy.
@en
type
label
Dyslipidemia: management using optimal lipid-lowering therapy.
@en
prefLabel
Dyslipidemia: management using optimal lipid-lowering therapy.
@en
P2860
P356
P1476
Dyslipidemia: management using optimal lipid-lowering therapy.
@en
P2093
Matthew K Ito
P2860
P304
P356
10.1345/APH.1R127
P407
P577
2012-10-02T00:00:00Z